Source: PharmaLive

Vifor Pharma: Vifor Pharma offers to rectify anti-competitive behavior against rival

Drug maker Vifor Pharma has offered to rectify its disparaging campaign against the closest rival to its blockbuster iron deficiency medicine Ferinject, EU antitrust regulators said on Friday, a move that would stave off a potential hefty fine and end an antitrust investigation.The post Vifor Pharma offers to rectify anti-competitive behavior against rival appeared first on PharmaLive.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Abbas Hussain's photo - CEO of Vifor Pharma

CEO

Abbas Hussain

CEO Approval Rating

83/100

Read more